2023-10-26T14:06:04-05:00 2023-07-31 010702717 PITTMAN & COMPANY LLP 8525 DOUGLAS AVE DES MOINES IA 50322 990 2022-08-01 421104334 IOWA ONCOLOGY RESEARCH ASSOCIATION IOWA 5152447586 1221 PLEASANT ST 450 DES MOINES IA 50309 JOSHUA LUKENBILL MD PRESIDENT/PRINCIPAL INVESTIGATOR 5152447586 2023-10-20 1 JOSHUA LUKENBILL MD XXX-XX-XXXX 0 JOHN PITTMAN CPA P00288858 5152762727 2023-10-20 X 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z JOSHUA LUKENBILL MD 1221 PLEASANT ST 450 DES MOINES IA 50309 1714782 0 X WWW.IORA.ORG X 1978 IA TO BE ENGAGED IN THE PURSUIT OF BASIC AND CLINICAL ONCOLOGICAL RESEARCH, WHILE PROMOTING OPTIMAL AND COMPREHENSIVE CARE FOR THE ONCOLOGY PATIENTS IN IOWA. THE ORGANIZATION IS FOUNDED ON THE PREMISES THAT HIGH QUALITY CLINICAL CANCER TREATMENT, CANCER CARE DELIVERY RESEARCH, AND CANCER CONTROL RESEARCH CAN BE CONDUCTED IN THE COMMUNITY BY ONCOLOGY PHYSICIANS, ONCOLOGY NURSE SPECIALISTS, CLINICAL RESEARCH ASSOCIATES, AND THAT THE COMMUNITY VENUE PROVIDES THE ULTIMATE PROVING GROUND FOR APPLICABILITY AND GENERALIZABILITY OF NEW CANCER TREATMENTS AND PREVENTION STRATEGIES FOR THE GENERAL POPULATION. 12 12 13 2 0 0 1239669 1313651 6437 382544 2 15 54419 18572 1300527 1714782 0 0 0 0 801207 929916 0 0 0 664048 829113 1465255 1759029 -164728 -44247 652663 583299 63359 38242 589304 545057 TO BE ENGAGED IN THE PURSUIT OF BASIC AND CLINICAL ONCOLOGICAL RESEARCH, WHILE PROMOTING OPTIMAL AND COMPREHENSIVE CARE FOR THE ONCOLOGY PATIENTS IN IOWA. 0 0 1464026 401116 ONCOLOGY RESEARCH 1464026 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 0 13 0 0 0 0 0 0 0 0 0 0 0 X 12 12 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 0 0 1 0 0 X THE ORGANIZATION 5152447586 1221 PLEASANT ST 450 DES MOINES IA 50309 X JOSHUA LUKENBILL PRESIDENT 5.00 X X 0 0 0 DEBORAH WILBUR MD VICE-PRESIDENT 5.00 X X 0 0 0 WENDY WOODS-SWAFFORD MD TREASURER 5.00 X X 0 0 0 JOSEPH MERCHANT SECRETARY 5.00 X X 0 0 0 WILLIAM FUSSELMAN MD MEMBER-AT-LARGE 1.00 X 0 0 0 ROBERT BEHRENS MEMBER-AT-LARGE 1.00 X 0 0 0 MICHAEL MARQUARDT MEMBER-AT-LARGE 1.00 X 0 0 0 NICK LOUDAS MEMBER-AT-LARGE 1.00 X 0 0 0 KATY JUHL PHARMD MEMBER-AT-LARGE 1.00 X 0 0 0 ARSHIN SHEYBANI MEMBER-AT-LARGE 1.00 X 0 0 0 SEEMA HARICHAND MEMBER-AT-LARGE 1.00 X 0 0 0 ABDELAZIZ ELHADDAD MEMBER-AT-LARGE 1.00 X 0 0 0 0 0 0 0 0 0 0 0 1600 1300000 12051 11981 1313651 PHARMACEUTICAL STUDIES 900099 293328 293328 ANCILLARY FUNDS 900099 89216 89216 382544 15 15 WAGE REIMBURSEMENT 900099 15572 15572 MISCELLANEOUS 900099 3000 3000 18572 1714782 401116 0 15 758585 597662 160923 111928 111928 59403 59403 62682 15277 47405 3034 3034 28973 28973 4696 4696 24257 24257 9598 9598 SUBRECIPIENTS 641977 641977 DUES & SUBSCRIPTIONS 31009 31009 IN-KIND 11981 11981 PHARMA STUDIES 6770 6770 4136 4136 1759029 1464026 295003 0 479499 452500 3568 3883 24449 6026 214063 93173 145147 120890 652663 583299 63359 38242 63359 38242 X 589304 545057 589304 545057 652663 583299 -44247 0 X 0 1 X 1 1 1 X IOWA METHODIST MEDICAL CENTER DES MOINES IA 102650 25093 77557 111413 68080 43333 120890 FORM 990, PART VI, SECTION B, LINE 11B A DRAFT OF THE FORM 990 WAS PROVIDED TO THE BOARD OF DIRECTORS FOR REVIEW PRIOR TO BEING FILED. FORM 990, PART VI, SECTION B, LINE 12C CONFLICT OF INTEREST FORMS ARE REVIEWED BY THE UNITY POINT INSTITUTIONAL REVIEW BOARD (IRB). IF ANY CONFLICTS ARE FOUND, THE IRB COMMUNICATES THOSE TO THE ORGANIZATION AND DEFINES ANY LIMITATIONS IN PARTICIPATING IN RESEARCH. FORM 990, PART VI, SECTION B, LINE 15A THE BOARD OF DIRECTORS EVALUATES SALARY SURVEYS FROM THE NATIONAL CANCER INSTITUTE AND SOCIETY OF CLINICAL RESEARCH ASSOCIATES. THESE SURVEYS ARE USED IN CONJUCTION WITH PERFORMANCE DATA TO DETERMINE EXECUTIVE DIRECTOR COMPENSATION. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S FINANCIAL STATEMENTS AND OTHER GOVERNING DOCUMENTS ARE AVAILABLE UPON REQUEST.